Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Fei Zhang & William C. Cho. (2023) Therapeutic potential of RUNX1 and RUNX2 in bone metastasis of breast cancer. Expert Opinion on Therapeutic Targets 27:6, pages 413-417.
Read now
Read now
Kah Min Yap, Mahendran Sekar, Lay Jing Seow, Siew Hua Gan, Srinivasa Reddy Bonam, Nur Najihah Izzati Mat Rani, Pei Teng Lum, Vetriselvan Subramaniyan, Yuan Seng Wu, Neeraj Kumar Fuloria & Shivkanya Fuloria. (2021) Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action. Breast Cancer: Targets and Therapy 13, pages 471-503.
Read now
Read now
Maria da Conceição Barros-Oliveira, Danylo Rafhael Costa-Silva, Danielle Benigno de Andrade, Umbelina Soares Borges, Vladimir Costa Silva, Rafael Soares Borges, Pedro Vitor Lopes-Costa, Airlane Pereira Alencar & Benedito Borges da Silva. (2017) Ki-67 antigen expression in the mammary epithelium of female rats in persistent estrus treated with anastrozole. Gynecological Endocrinology 33:5, pages 359-362.
Read now
Read now
D. V. Byreddy, M. F. Bouchonville II & E. M. Lewiecki. (2015) Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors. Climacteric 18:sup2, pages 39-46.
Read now
Read now
Articles from other publishers (33)
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, Maria Sinicropi & Alessia Catalano. (2023) Targeting Breast Cancer: An Overlook on Current Strategies. International Journal of Molecular Sciences 24:4, pages 3643.
Crossref
Crossref
Pooja Ratre, Swanand Kulkarni, Sweety Das, Chengyuan Liang, Pradyumna Kumar Mishra & Suresh Thareja. (2022) Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview. Medical Oncology 40:1.
Crossref
Crossref
Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, Valamla Bhavana, Anuradha Urati, Dharmendra Khatri, Shashi Bala Singh & Neelesh Kumar Mehra. (2022) Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer. Journal of Controlled Release 352, pages 1024-1047.
Crossref
Crossref
Derya Osmaniye, Şevval Karaca, Berkant Kurban, Merve Baysal, Iqrar Ahmad, Harun Patel, Yusuf Özkay & Zafer Asım Kaplancıklı. (2022) Design, synthesis, molecular docking and molecular dynamics studies of novel triazolothiadiazine derivatives containing furan or thiophene rings as anticancer agents. Bioorganic Chemistry 122, pages 105709.
Crossref
Crossref
Agostino Gaudio, Anastasia Xourafa, Rosario Rapisarda & Pietro Castellino. (2022) Therapeutic Options for the Management of Aromatase Inhibitor-
Associated Bone Loss. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:3, pages 259-273.
Crossref
Crossref
Ratchanok Pingaew, Vanida Choomuenwai, Ronnakorn Leechaisit, Veda Prachayasittikul, Supaluk Prachayasittikul & Virapong Prachayasittikul. (2022) 1,2,3-Triazole Scaffold in Recent Medicinal Applications: Synthesis and Anticancer Potentials. HETEROCYCLES 105:1, pages 147.
Crossref
Crossref
Kah Min Yap, Mahendran Sekar, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Lay Jing Seow, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria & Pei Teng Lum. (2021) Hesperidin and its aglycone hesperetin in breast cancer therapy: A review of recent developments and future prospects. Saudi Journal of Biological Sciences 28:12, pages 6730-6747.
Crossref
Crossref
Sara Behbahani, Amaris Geisler, Avani Kolla, Margaret Rush Dreker, Genevieve Kaunitz & Miriam K. Pomeranz. (2021) Art of prevention: The importance of dermatologic care when using aromatase inhibitors. International Journal of Women's Dermatology 7:5, pages 769-773.
Crossref
Crossref
Sara Caceres, Beatriz Monsalve, Angela Alonso-Diez, Belén Crespo, Maria Jose Illera, Paloma Jimena de Andres, Gema Silvan & Juan Carlos Illera. (2021) Blocking Estrogen Synthesis Leads to Different Hormonal Responses in Canine and Human Triple Negative Inflammatory Breast Cancer. Cancers 13:19, pages 4967.
Crossref
Crossref
Sudesh Rani, Konpal Raheja, Vijay Luxami & Kamaldeep Paul. (2021) A review on diverse heterocyclic compounds as the privileged scaffolds in non-steroidal aromatase inhibitors. Bioorganic Chemistry 113, pages 105017.
Crossref
Crossref
Frederico Arthur Pereira Nunes, Maria Lucia Fleiuss de Farias, Felipe Peres Oliveira, Leonardo VieiraNetoNeto, Luis Felipe Cardoso Lima, Francisco de Paula ParanhosNetoNeto, Laura Maria Carvalho de Mendonça & Miguel Madeira. (2021) Use of aromatase inhibitors in patients with breast cancer is associated with deterioration of bone microarchitecture and density. Archives of Endocrinology and Metabolism.
Crossref
Crossref
Xue-Ling Xu, Shou-Long Deng, Zheng-Xing Lian & Kun Yu. (2021) Estrogen Receptors in Polycystic Ovary Syndrome. Cells 10:2, pages 459.
Crossref
Crossref
Simone Diedrichsen Marstrand, Kristian Buch-Larsen, Michael Andersson, Lars Thorbjørn Jensen & Peter Schwarz. (2021) Heart rate variability and vibration perception threshold to assess chemotherapy-induced neuropathy in women with breast cancer – a systematic review. Cancer Treatment and Research Communications 26, pages 100295.
Crossref
Crossref
Sayanta Dutta, Sushweta Mahalanobish & Parames C. Sil. 2021. Discovery and Development of Anti-Breast Cancer Agents from Natural Products. Discovery and Development of Anti-Breast Cancer Agents from Natural Products
197
229
.
Phanruethai Pailee, Hunsa Prawat, Poonsakdi Ploypradith, Chulabhorn Mahidol, Somsak Ruchirawat & Vilailak Prachyawarakorn. (2020) Atalantiaphyllines A-G, prenylated acridones from Atalantia monophylla DC. and their aromatase inhibition and cytotoxic activities. Phytochemistry 180, pages 112525.
Crossref
Crossref
Cristina Ferreira Almeida, Ana Oliveira, Maria João Ramos, Pedro A. Fernandes, Natércia Teixeira & Cristina Amaral. (2020) Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach?. Biochemical Pharmacology 177, pages 113989.
Crossref
Crossref
Rosa Luz Luna-Palencia & Eliseo Neftali De la Cruz-Escobar. (2020) Actualidades en el manejo sistémico del cáncer de mama. Revista Mexicana de Mastología 10:3, pages 71-82.
Crossref
Crossref
Yue Zhao, Chenxi Zhao, Jin Lu, Jun Wu, Changhao Li, Zhiye Hu, Wei Tian, Liang Yang, Jin Xiang, Haibin Zhou, Zixin Deng, Jian Huang & Kui Hong. (2019) Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader. Pharmacological Research 146, pages 104294.
Crossref
Crossref
Simone Mocellin, Annabel Goodwin & Sandro Pasquali. (2019) Risk-reducing medications for primary breast cancer: a network meta-analysis. Cochrane Database of Systematic Reviews 2019:4.
Crossref
Crossref
Kristian Buch, Victoria Gunmalm, Michael Andersson, Peter Schwarz & Charlotte Brøns. (2019) Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review. Cancer Medicine 8:1, pages 238-245.
Crossref
Crossref
Waleeporn Kaewlert, Chadamas Sakonsinsiri, Nisana Namwat, Kanlayanee Sawanyawisuth, Piti Ungarreevittaya, Narong Khuntikeo, Napat Armartmuntree & Raynoo Thanan. (2018) The Importance of CYP19A1 in Estrogen Receptor-Positive Cholangiocarcinoma. Hormones and Cancer 9:6, pages 408-419.
Crossref
Crossref
Mariam Abotaleb, Peter Kubatka, Martin Caprnda, Elizabeth Varghese, Barbora Zolakova, Pavol Zubor, Radka Opatrilova, Peter Kruzliak, Patrik Stefanicka & Dietrich Büsselberg. (2018) Chemotherapeutic agents for the treatment of metastatic breast cancer: An update. Biomedicine & Pharmacotherapy 101, pages 458-477.
Crossref
Crossref
F. Scott Heinemann, Alice Police, Erin Lin, Mandy Liu, Sherry Liang & Ying Huang. 2018. Genomics-Driven Healthcare. Genomics-Driven Healthcare
331
372
.
Maria da Conceição Barros-Oliveira, Danylo Rafhael Costa-Silva, Danielle Benigno de Andrade, Umbelina Soares Borges, Cléciton Braga Tavares, Rafael Soares Borges, Janaína de Moraes Silva & Benedito Borges da Silva. (2017) Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review. Revista da Associação Médica Brasileira 63:4, pages 371-378.
Crossref
Crossref
Philip R. Cohen. (2017) Melasma treatment: A novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. Medical Hypotheses 101, pages 1-5.
Crossref
Crossref
Xu-Hui Huang, Rong-Hua Liang, Le Su, Wei Guo & Chang-Jun Wang. (2017) Mechanism of Bushen Jianpi decoction in preventing and treating osteoporosis caused by aromatase inhibitors in breast cancer treatment. Cancer Biomarkers 18:2, pages 183-190.
Crossref
Crossref
Polina Weitzenfeld, Tsipi Meshel & Adit Ben-Baruch. (2016) Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Oncotarget 7:49, pages 81123-81143.
Crossref
Crossref
Gian Mario Tiboni & Adalisa Ponzano. (2016) Fetal safety profile of aromatase inhibitors: Animal data. Reproductive Toxicology 66, pages 84-92.
Crossref
Crossref
Ian M. Bird & David H. Abbott. (2016) The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature. The Journal of Steroid Biochemistry and Molecular Biology 163, pages 136-146.
Crossref
Crossref
Wanjun Lin, Jiajun Huang, Xiaolin Liao, Zhongwen Yuan, Senling Feng, Ying Xie & Wenzhe Ma. (2016) Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha. Pharmacological Research 111, pages 849-858.
Crossref
Crossref
Simone Mocellin, Annabel Goodwin & Sandro Pasquali. (2016) Risk-reducing medication for primary breast cancer: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Frederik Marmé. 2016. Management of Breast Diseases. Management of Breast Diseases
335
390
.
ALICIA GONZÁLEZ, CARLOS MARTÍNEZ-CAMPA, CAROLINA ALONSO-GONZÁLEZ & SAMUEL COS. (2015) Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase. International Journal of Molecular Medicine 36:6, pages 1671-1676.
Crossref
Crossref